Breathe BioMedical Inc. (BRTH)
Breathe BioMedical will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Breathe BioMedical Statistics
Total Valuation
Market Cap | n/a |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 19.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6,075.51% and return on invested capital (ROIC) is -325.59%.
Return on Equity (ROE) | -6,075.51% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -325.59% |
Revenue Per Employee | n/a |
Profits Per Employee | -$293,783 |
Employee Count | 26 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.30M |
Pretax Income | -7.71M |
Net Income | -7.64M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $1.85 million in cash and $2.42 million in debt, giving a net cash position of -$571,578.
Cash & Cash Equivalents | 1.85M |
Total Debt | 2.42M |
Net Cash | -571,578 |
Net Cash Per Share | n/a |
Equity (Book Value) | 126,904 |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$4.51 million and capital expenditures -$592,074, giving a free cash flow of -$5.11 million.
Operating Cash Flow | -4.51M |
Capital Expenditures | -592,074 |
Free Cash Flow | -5.11M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BRTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |